Biden White House Hammered By FDA in Twin Rulings
#Biden #WhiteHouse #FDA #vaccine #vaccinations
"FDA Backs COVID-19 Boosters Only for Elderly and Those at High Risk"-- Paul Ebeling
Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra dose only for those who are 65 anni or older or run a high risk of severe disease.
The twin votes represented a heavy blow to Mr. Biden's sweeping effort, announced a month ago, to shore up nearly all Americans' protection from the spread of the Delta variant.
The decision was made by an influential committee of outside experts who advise the Food and Drug Administration.
In a surprising turn, the panel rejected, by a vote of 16-2, boosters for almost everyone.
Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups.
Then, in an 18-0 vote, it endorsed the extra shot for select portions of the US population, namely, those most at risk from the virus.
Have a happy, healthy weekend, Keep the Faith!

Biohacking: The Science of Optimizing Longevity
An evidence-led, optimistic tour of biohacking: what it is, why the science is sound, and how the movement is converging with clinical longevity medicine of the kind practised at Bangkok's Target150.

NK Cells: Powerful Cancer Fighters
Natural killer (NK) cells are the immune system’s first line of defense against cancer. This 2026 guide covers NK cell biology, how they destroy tumors, the latest CAR-NK and memory-like breakthroughs from Dana-Farber, MIT, Yale and McGill, and how to support your own NK cell function.
China’s Economic Resilience
Saudi Arabia Bolsters Defense Manufacturing with BAE Systems Arabian Industries
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.

